[
    [
        {
            "time": "2021-04-15",
            "original_text": "['COVID-19', 'variants', \"'are\", 'going', 'to', 'be', 'the', 'wild', \"card':\", 'Doctor']",
            "features": {
                "keywords": [
                    "COVID-19",
                    "variants",
                    "wild card"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "COVID-19 variants 'are going to be the wild card': Doctor",
                "Correlation": 3,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 1,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-04-15",
            "original_text": "['Emergent', 'Has', 'Made', 'Over', '100', 'Million', 'Doses', 'of', 'J&J', 'Covid-19', 'Vaccine,', 'CEO', 'Says']",
            "features": {
                "keywords": [
                    "Emergent",
                    "J&J",
                    "vaccine",
                    "doses"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Emergent Has Made Over 100 Million Doses of J&J Covid-19 Vaccine, CEO Says",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-04-15",
            "original_text": "['There’s', '‘always', 'a', \"concern'\", 'of', 'another', 'COVID-19', 'wave:', 'Doctor']",
            "features": {
                "keywords": [
                    "COVID-19",
                    "wave",
                    "concern"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "There’s ‘always a concern' of another COVID-19 wave: Doctor",
                "Correlation": 3,
                "Sentiment": 4,
                "Importance": 5,
                "Impact": 3,
                "Duration": 5,
                "Entity_Density": 1,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-04-15",
            "original_text": "['Emergent', 'shares', 'slide', '2.8%', 'as', 'execs', 'blame', 'J&J', 'vaccine', 'snafu', 'on', 'challenge', 'of', 'making', 'two', 'vaccines', 'to', 'scale']",
            "features": {
                "keywords": [
                    "Emergent",
                    "shares",
                    "slide",
                    "J&J",
                    "vaccine",
                    "snafu"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Emergent shares slide 2.8% as execs blame J&J vaccine snafu on challenge of making two vaccines to scale",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-04-15",
            "original_text": "['UPDATE', '3-Emergent', 'may', 'be', 'able', 'to', 'resume', 'J&J', 'COVID-19', 'shot', 'production', \"'within\", \"days'\" '-CEO']",
            "features": {
                "keywords": [
                    "Emergent",
                    "resume",
                    "J&J",
                    "production"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "UPDATE 3-Emergent may be able to resume J&J COVID-19 shot production 'within days' -CEO",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "2021-04-15",
            "original_text": "['Emergent', 'BioSolutions', 'plans', 'as', 'early', 'as', 'July', 'to', 'correct', 'problems', 'that', 'ruined', 'COVID-19', 'shots', '-', 'U.S.', 'House', 'memo']",
            "features": {
                "keywords": [
                    "Emergent",
                    "BioSolutions",
                    "correct",
                    "problems",
                    "COVID-19",
                    "shots"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Emergent BioSolutions plans as early as July to correct problems that ruined COVID-19 shots - U.S. House memo",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-04-15",
            "original_text": "[\"'Vaccinated\", 'people', 'are', 'exceedingly', \"safe,'\", 'doctor', 'stresses', 'amid', 'reports', 'of', 'breakthrough', 'cases']",
            "features": {
                "keywords": [
                    "vaccinated",
                    "people",
                    "safe",
                    "breakthrough",
                    "cases"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Vaccinated people are exceedingly safe, doctor stresses amid reports of breakthrough cases",
                "Correlation": 3,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 2,
                "Duration": 4,
                "Entity_Density": 1,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-04-15",
            "original_text": "[\"India's\", 'Biological', 'E', 'To', 'Make', 'Johnson', '&', \"Johnson's\", 'COVID-19', 'Shots:', 'Reuters']",
            "features": {
                "keywords": [
                    "India",
                    "Biological",
                    "E",
                    "Johnson",
                    "&",
                    "Johnson",
                    "COVID-19",
                    "Shots"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "India's Biological E To Make Johnson & Johnson's COVID-19 Shots: Reuters",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-04-15",
            "original_text": "['These', 'Are', 'the', 'Safest', 'Dividend', 'Stocks', 'in', 'the', 'World']",
            "features": {
                "keywords": [
                    "Safest",
                    "Dividend",
                    "Stocks"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "These Are the Safest Dividend Stocks in the World",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-04-15",
            "original_text": "['Step', 'Aside,', 'Dogecoin', '--', 'This', 'Stock', 'Has', 'Delivered', 'a', 'Gain', 'of', 'Over', '1,100,000%']",
            "features": {
                "keywords": [
                    "Dogecoin",
                    "Stock",
                    "Gain",
                    "1,100,000%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Step Aside, Dogecoin -- This Stock Has Delivered a Gain of Over 1,100,000%",
                "Correlation": 6,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 10,
                "Source_Recency": 7
            }
        }
    ]
]